Roche's Soriot leaving to head AZN

Pascal Soriot will depart as COO of the pharmaceuticals division at Roche (SIX:ROG; OTCQX:RHHBY) to become CEO of AstraZeneca plc (LSE:AZN; NYSE:AZN), effective Oct. 1. He replaces interim CEO Simon Lowth, who will resume his role as CFO. Lowth became interim CEO in June after David Brennan retired. ...